Systematic review of associations between anxiety, depression, and functional/biological aging among cancer survivors
Systematische Übersicht zu Zusammenhängen zwischen Angst, Depression und funktionellem/biologischem Altern bei Krebsüberlebenden
JNCI Cancer Spectrum · 01.11.2024 · 8 (6)
DOI: 10.1093/jncics/pkae100 ↗Auf einen Blick
Die Übersicht fand überwiegend positive Zusammenhänge zwischen Angst, Depression und Altern bei Krebsüberlebenden. Besonders deutlich waren die Befunde für funktionelles Altern und Depression.
Fragestellung
Wie sind Angst und Depression bei Krebsüberlebenden mit funktionellem und biologischem Altern assoziiert?
Methode
Systematische Übersicht; Suche in PubMed, Embase, CINAHL, Web of Science und PsycNet zu Studien von 2012 bis 2022; methodische Bewertung der Daten.
Ergebnisse
51 Studien eingeschlossen; 53 % querschnittlich. 35 Studien zu funktionellem und 16 zu biologischem Altern. Es wurden 223 Assoziationen geprüft; die Zusammenhänge waren insgesamt meist positiv.
Einschränkungen
Hinweise auf Selektions- und Messverzerrungen.
Schlussfolgerung der Autor:innen
Die Befunde sprechen für positive Zusammenhänge zwischen Angst, Depression und Altern bei Krebsüberlebenden. Weitere Forschung ist nötig zu zeitlichem Verlauf, Altersmessung und vielfältigeren Kohorten.
Kernaussagen
- 51 Studien; 223 geprüfte Assoziationen
- Positive Zusammenhänge insgesamt, besonders bei funktionellem Altern und Depression
- Hinweise auf Selektions- und Messverzerrungen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 23.10.2024. Verfasst von Brennan Parmelee Streck und 5 weiteren Autor:innen. Beteiligte Einrichtung: Basic Biobehavioral and Psychological Sciences Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD 2…. Hauptthemen laut MEDLINE: Cancer Survivors, Depression, Anxiety, Aging. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Cancer Institute's Intramural Continuing Umbrella for Research Experiences, National Cancer Institute’s Intramural Continuing Umbrella for Research Experiences.
Themen: Depression
Abstract (Originalsprache)
Background
Evidence suggests a mind-body component to aging through which psychological distress from anxiety and depression drives molecular changes that promote early decline (ie, accelerated aging). Cancer survivors experience particularly high rates of anxiety and depression. Some survivors also have accelerated aging, though the relationships between anxiety and depression and aging are not clear. A synthesis of evidence is needed to understand the state of the science and impending priorities.
Methods
PubMed, Embase, CINAHL, Web of Science, and PsycNet databases were searched for studies that measured associations between depression, anxiety, and nonchronological aging in cancer survivors (2012-2022). Data were methodologically evaluated.
Results
Survivorship studies were included if they were peer reviewed, published in English from 2012 to 2022, and measured associations between anxiety and depression and aging. In total, 51 studies were included. Just over half were cross-sectional (53%). Foci included functional (n = 35 [69%]) and biological (n = 16 [31%]). Functional aging measures included frailty, sarcopenia, geriatric assessment, and cognition. Biological aging measures included telomere length, telomerase, age-related inflammatory blood-based biomarkers, renal insufficiency, anemia, and DNA methylation. We tested 223 associations. Associations between anxiety, depression, and aging were generally positive, though with varying strengths. Most compelling were associations between functional aging and depression. There were concerns for selection and measurement biases.
Conclusions
Findings suggest positive associations between anxiety, depression, and aging among cancer survivors. Future work is needed to clarify temporality, develop a consensus on the measurement of aging, and diversify cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Basic Biobehavioral and Psychological Sciences Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD 20850, United States.
- Neurooncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20814, United States.
- School of Health and Rehabilitation Sciences, Department of Occupational Therapy, The University of Pittsburgh, Pittsburgh, PA 15219, United States.
- National Institutes of Health Library, Office of Research Services, Office of the Director, National Institutes of Health, Bethesda, MD 20892, United States.
ORCID-Profile: Brennan Parmelee Streck, Alicia A Livinski, Jennifer L Guida
Förderung
- National Cancer Institute's Intramural Continuing Umbrella for Research Experiences
- National Cancer Institute’s Intramural Continuing Umbrella for Research Experiences
Zitieren
APA
Streck, B. P., Sass, D., Brick, R., Fisk, L., Livinski, A. A., & Guida, J. L. (2024). Systematic review of associations between anxiety, depression, and functional/biological aging among cancer survivors. JNCI Cancer Spectrum, 8(6). https://doi.org/10.1093/jncics/pkae100
Vancouver
Streck BP, Sass D, Brick R, Fisk L, Livinski AA, Guida JL. Systematic review of associations between anxiety, depression, and functional/biological aging among cancer survivors. JNCI Cancer Spectrum. 2024;8(6). doi:10.1093/jncics/pkae100
BibTeX
@article{Streck2024,
author = {Streck, Brennan Parmelee and Sass, Dilorom and Brick, Rachelle and Fisk, Leah and Livinski, Alicia A and Guida, Jennifer L},
title = {Systematic review of associations between anxiety, depression, and functional/biological aging among cancer survivors},
journal = {JNCI Cancer Spectrum},
year = {2024},
volume = {8},
number = {6},
doi = {10.1093/jncics/pkae100}
}
EUVIMED